Does EZETIMIBE\SIMVASTATIN Cause Dysmorphism? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Dysmorphism have been filed in association with EZETIMIBE\SIMVASTATIN. This represents 0.7% of all adverse event reports for EZETIMIBE\SIMVASTATIN.
13
Reports of Dysmorphism with EZETIMIBE\SIMVASTATIN
0.7%
of all EZETIMIBE\SIMVASTATIN reports
12
Deaths
0
Hospitalizations
How Dangerous Is Dysmorphism From EZETIMIBE\SIMVASTATIN?
Of the 13 reports, 12 (92.3%) resulted in death.
Is Dysmorphism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE\SIMVASTATIN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE\SIMVASTATIN Cause?
Myalgia (244)
Acute kidney injury (132)
Rhabdomyolysis (113)
Drug hypersensitivity (112)
Arthralgia (89)
Diarrhoea (71)
Muscle spasms (70)
No adverse event (68)
Fatigue (66)
Rash (54)
What Other Drugs Cause Dysmorphism?
VALPROATE (552)
LAMOTRIGINE (134)
VALPROIC ACID (128)
LEVETIRACETAM (113)
CARBAMAZEPINE (85)
CLOBAZAM (54)
TOPIRAMATE (54)
DIVALPROEX (53)
ONDANSETRON (52)
QUETIAPINE (49)
Which EZETIMIBE\SIMVASTATIN Alternatives Have Lower Dysmorphism Risk?
EZETIMIBE\SIMVASTATIN vs EZOGABINE
EZETIMIBE\SIMVASTATIN vs FACTOR XIII CONCENTRATE
EZETIMIBE\SIMVASTATIN vs FAM-TRASTUZUMAB DERUXTECAN-NXKI
EZETIMIBE\SIMVASTATIN vs FAMCICLOVIR
EZETIMIBE\SIMVASTATIN vs FAMOTIDINE